Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 4/20 | 0.42 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.42 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.42 |
| ▸ | HPGD | P15428 | 4/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.42 |
| ▸ | CYP1A2 | P05177 | 3/20 | 0.42 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.42 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.42 |
| ▸ | GLA | P06280 | 1/20 | 0.42 |
| ▸ | LMNA | P02545 | 4/20 | 0.38 |
| ▸ | NCEH1 | Q6PIU2 | 1/20 | 0.38 |
| ▸ | MAPT | P10636 | 3/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | GPR84 | Q9NQS5 | 1/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.36 |
| ▸ | ERN1 | O75460 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.35 |
| ▸ | NPC1 | O15118 | 2/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9279307 | 0.88 | HPGD (0.39) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL8370153 | 0.83 | TSPO (0.41) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL27556715 | 0.83 | MEN1 (0.42) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL3999298 | 0.82 | ALDH1A1 (0.55) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL7941266 | 0.80 | ESRRA (0.37) | MEN1KMT2AHPGDALDH1A1HSD17B10 | |
| SCHEMBL8153278 | 0.79 | CYP2A6 (0.47) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL29243294 | 0.75 | GPR84 (0.46) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL10771028 | 0.74 | KMT2A (0.66) | MEN1KMT2AKDM4EHPGDALDH1A1 | |
| SCHEMBL27556714 | 0.73 | CYP1A2 (0.42) | MEN1KMT2AKDM4EALDH1A1CYP1A2 | |
| SCHEMBL10352802 | 0.71 | KDM4E (0.42) | MEN1KMT2AKDM4EHPGDALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 103 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240084109-A1 | THERMOPLASTIC PULVERULENT COMPOSITION FOR THREE-DIMENSIONAL PRINTING | BASF SE (DE) | 2024-03-14 | — | — | US | disclosed |
| EP-4271550-A1 | THERMOPLASTIC PULVERULENT COMPOSITION FOR THREE-DIMENSIONAL PRINTING | BASF SE (DE) | 2023-11-08 | — | — | EP | disclosed |
| EP-4247618-A1 | FLAME-RETARDANT PULVERULENT COMPOSITION AND 3D-PRINTED OBJECT OBTAINED FROM THE SAME | BASF SE (DE) | 2023-09-27 | — | — | EP | disclosed |
| WO-2022144160-A1 | THERMOPLASTIC PULVERULENT COMPOSITION FOR THREE-DIMENSIONAL PRINTING | BASF SE (DE) | 2022-07-07 | — | — | WO | disclosed |
| WO-2022106402-A1 | FLAME-RETARDANT PULVERULENT COMPOSITION AND 3D-PRINTED OBJECT OBTAINED FROM THE SAME | BASF SE (DE) | 2022-05-27 | — | — | WO | disclosed |
| CN-107278219-B | Deoxybenzoin-containing flame-retardant polymer composition | 巴斯夫欧洲公司 | 2021-03-05 | — | — | CN | disclosed |
| EP-2825589-B1 | NOR-HALS COMPOUNDS AS FLAME RETARDANTS | BASF SE (DE) | 2020-05-06 | — | — | EP | disclosed |
| US-10414985-B2 | Heptaphosphorus-derived compounds as flame retardants | BASF SE (DE) | 2019-09-17 | — | — | US | disclosed |
| US-10316169-B2 | NOR-HALS compounds as flame retardants | BASF SE (DE) | 2019-06-11 | — | — | US | disclosed |
| US-20180216008-A1 | HEPTAPHOSPHORUS-DERIVED COMPOUNDS AS FLAME RETARDANTS | BASF SE (DE) | 2018-08-02 | — | — | US | disclosed |
| EP-1987094-A1 | AROMATIC PHOSPHATE ACID ESTER FLAME RETARDANT COMPOSITIONS | Ciba Holding Inc. (CH) | 2008-11-05 | — | — | EP | disclosed |
| EP-1984440-A1 | AROMATIC SULPHONATE FLAME RETARDANT COMPOSITIONS | Ciba Holding Inc. (CH) | 2008-10-29 | — | — | EP | disclosed |
| WO-2008119693-A1 | DOPO FLAME RETARDANT COMPOSITIONS | BASF SE (CH) | 2008-10-09 | — | — | WO | disclosed |
| EP-1915427-A1 | POLYCARBONATE FLAME RETARDENT COMPOSITIONS | Ciba Specialty Chemicals Holding Inc. (CH) | 2008-04-30 | — | — | EP | disclosed |
| WO-2007096260-A1 | AROMATIC PHOSPHATE ACID ESTER FLAME RETARDANT COMPOSITIONS | CIBA HOLDING INC. (CH) | 2007-08-30 | — | — | WO | disclosed |
| WO-2007093513-A1 | AROMATIC SULPHONATE FLAME RETARDANT COMPOSITIONS | CIBA HOLDING INC. (CH) | 2007-08-23 | — | — | WO | disclosed |
| WO-2007020211-A1 | POLYCARBONATE FLAME RETARDENT COMPOSITIONS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 2007-02-22 | — | — | WO | disclosed |
| US-5191036-A | Polycarbonate, aromatic polyestersiloxane block polymer, impact strength | MITSUBISHI RAYON CO., LTD. (JP) | 1993-03-02 | — | — | US | disclosed |
| US-5084527-A | Polyestersiloxane copolymers for impact strength | MITSUBISHI RAYON CO., LTD. (JP) | 1992-01-28 | — | — | US | disclosed |
| EP-0384460-A1 | Thermoplastic resin composition | MITSUBISHI RAYON CO., LTD (JP) | 1990-08-29 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180216008-A1 | HEPTAPHOSPHORUS-DERIVED COMPOUNDS AS FLAME RETARDANTS | PFAS, PCBP1, DDT | MEN1 3373/4885KMT2A 1171/4885KDM4E 1196/4885 |
| US-10414985-B2 | Heptaphosphorus-derived compounds as flame retardants | PFAS, PCBP1, DDT | MEN1 1640/4885KMT2A 1058/4885KDM4E 1397/4885 |
| US-10316169-B2 | NOR-HALS compounds as flame retardants | PFAS, NONO, PARG | MEN1 4290/4885KMT2A 1032/4885KDM4E 982/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.